Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

UroGen Pharma shows positive results for bladder cancer patients

October 6, 2021 Research and Development

UroGen Pharma Ltd has published results from the Phase IIb OPTIMA II trial, a single-arm trial studying UGN-102 (mitomycin) as …
News

Third dose of COVID-19 vaccine approved for immunocompromised over 12

October 6, 2021 Research and Development

The EMA have authorised the third dose of the Moderna COVID-19 vaccine (Spikevax), to be administered on immunocompromised individuals aged …
News

Merck secures Singapore deal for COVID antiviral pill

October 6, 2021 Medical Communications, Research and Development

Merck announced on Wednesday a supply and purchase agreement that will provide Singapore with access to its experimental oral COVID-19 …
News

Bayer wins first court case in Roundup child cancer battle

October 6, 2021 Medical Communications, Research and Development

Bayer AG has won its first court case over claims its Roundup weed killer causes cancer after a California jury …
News

Brain implant can lift severe depression, study finds

October 5, 2021 Manufacturing and Production, Research and Development

Researchers from the University of California have created an electrical implant that sits in the skull, wired to the brain, …
News

NICE recommends first new sickle cell disease treatment in 20 years

October 5, 2021 Manufacturing and Production, Medical Communications, Research and Development

NICE has announced on Tuesday that for the first time in 20 years, a new treatment will be made available …
News
az

FDA grants BTD for Daiichi Sankyo and AstraZeneca’s Enhertu

October 4, 2021 Research and Development, Sales and Marketing

AstraZeneca and Daiichi Sankyo have today announced that the FDA has granted Enhertu (fam-trastuzumab deruxtecan-nxki) breakthrough therapy designation (BTD) for …
News

Avacta reaches milestone in LG Chem partnership

September 29, 2021 Research and Development

Clinical stage biopharmaceutical company, Avacta Group plc, has announced that a preclinical development milestone has been achieved in the partnership …
News
39736431593_abc529f43d_c

Novartis autoinjector effective for treating psoriasis

September 29, 2021 Research and Development

New data show that Novartis Cosentyx (secukinumab) 300-mg single dose autoinjector resulted in high efficacy vs placebo. Cosentyx is a …
News
white-shutterstock_71287333

Acacia Pharma’s new cancer care injection approved in Europe

September 29, 2021 Research and Development

Biopharmaceutical company Acacia Pharma Group plc (Acacia Pharma) has announced that its Marketing Authorisation Application (MAA) for BARHEMSYS® (amisulpride injection) …
News

Vitamin A nasal spray being trialled for COVID smell loss

September 29, 2021 Research and Development

The University of East Anglia is conducting a 12-week trial to investigate the use of vitamin A nasal spray to …
News

Several rival companies set to launch antiviral pills for COVID-19

September 29, 2021 Research and Development

With Merck and Pfizer preparing to release clinical trial results from its experimental COVID-19 antiviral pills, rivals are lining up …
News

Eisai launch bid for accelerated FDA approval for new Alzheimer’s drug

September 28, 2021 Manufacturing and Production, Medical Communications, Research and Development

Japanese drug maker Eisai has launched a bid for accelerated FDA approval for its new experimental drug for early Alzheimer’s …
News
white-46040b7c-9161-4bd9-82b0-b36120519a07_1_1

Children in India to receive COVID-19 vaccine from October

September 22, 2021 Research and Development

  All Indian children aged 12 or older will become eligible for their COVID-19 vaccinations from next month, in the …
News
christianschetter

Dr. Christian Schetter hired as Chief Scientific Officer at Rentschler Biopharma

September 22, 2021 Research and Development

Rentschler Biopharma has announced the appointment of Dr. Christian Schetter as their new CSO. In this position, Schetter will be …
Appointment
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026